Search hospitals > Texas > Houston
Pioneer Research Solutions Inc.
Claim this profileHouston, Texas 77099
Global Leader in Arthritis
Global Leader in Rheumatoid Arthritis
Conducts research for Type 2 Diabetes
Conducts research for Syndrome
Conducts research for Non-alcoholic Fatty Liver Disease
92 reported clinical trials
2 medical researchers
Summary
Pioneer Research Solutions Inc. is a medical facility located in Houston, Texas. This center is recognized for care of Arthritis, Rheumatoid Arthritis, Type 2 Diabetes, Syndrome, Non-alcoholic Fatty Liver Disease and other specialties. Pioneer Research Solutions Inc. is involved with conducting 92 clinical trials across 80 conditions. There are 2 research doctors associated with this hospital, such as Francisco Velazquez, MD and Asif Cochinwala.Area of expertise
1Arthritis
Global LeaderRheumatoid factor positive
Anti-cyclic citrullinated peptide autoantibodies positive
2Rheumatoid Arthritis
Global LeaderRheumatoid factor positive
Anti-cyclic citrullinated peptide autoantibodies positive
Top PIs
Francisco Velazquez, MDPioneer Research Solutions Inc3 years of reported clinical research
Studies Non-alcoholic Fatty Liver Disease
Studies Fatty Liver Disease
8 reported clinical trials
9 drugs studied
Asif CochinwalaPioneer Research Solutions, Inc.3 years of reported clinical research
Studies Arthritis
Studies Rheumatoid Arthritis
3 reported clinical trials
5 drugs studied
Clinical Trials running at Pioneer Research Solutions Inc.
Non-alcoholic Fatty Liver Disease
Gout
Fatty Liver Disease
Hypertriglyceridemia
High Triglycerides
Irritable Bowel Syndrome
Type 2 Diabetes
Constipation
Syndrome
Systemic Lupus Erythematosus
Lanifibranor
for Nonalcoholic Steatohepatitis (NASH)
This study is evaluating whether a drug called lanifibranor can improve liver health in people with nonalcoholic steatohepatitis.
Recruiting1 award Phase 31 criteria
ALN-HSD
for NASH with Fibrosis
This study is researching an investigational drug called ALN-HSD (called "study drug"). This study is focused on participants who are known to have non-alcoholic steatohepatitis (NASH). NASH is a form of non-alcoholic fatty liver disease (NAFLD). Recently, the name metabolic dysfunction associated steatohepatitis (MASH) has been introduced to replace NASH and metabolic dysfunction-associated steatotic liver disease (MASLD) to replace NAFLD. NASH occurs when fat builds up in liver cells, damaging them, and making the liver inflamed and stiff from fibrosis (scar tissue). NASH can progress to cirrhosis (long term scarring) and liver failure (when the liver cannot perform its job). The aim of the study is to see the effect of the study drug on lessening liver scarring side effects related to NASH. The study is looking at several other research questions, including: How the study drug works to improve liver function and lessen NASH related inflammation in the liver What side effects may happen from receiving the study drug How much study drug and study drug metabolites (byproduct of the body breaking down the study drug) are in the blood at different times Better understanding of the study drug and NASH
Recruiting0 awards Phase 22 criteria
HM15211
for Non-alcoholic Steatohepatitis (NASH)
This study is evaluating whether a drug may help treat nonalcoholic steatohepatitis.
Recruiting0 awards Phase 23 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Pioneer Research Solutions Inc.?
Pioneer Research Solutions Inc. is a medical facility located in Houston, Texas. This center is recognized for care of Arthritis, Rheumatoid Arthritis, Type 2 Diabetes, Syndrome, Non-alcoholic Fatty Liver Disease and other specialties. Pioneer Research Solutions Inc. is involved with conducting 92 clinical trials across 80 conditions. There are 2 research doctors associated with this hospital, such as Francisco Velazquez, MD and Asif Cochinwala.